Repositioning Candidates

Repositioning candidates for NAFLD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and NAFLD-associated disease in NAFLDkb are presented with knowledge graphs.

stats1
stats2
stats3

Search for:

     Cerebrovascular
12 records.
Candidate ID Source ID Source Type Compound Type Candidate Name Inclusion Criteria
R0227 DB00641 approved small molecule Simvastatin Therapeutic strategy associated Details
R0246 DB00699 approved; investigational small molecule Nicergoline Therapeutic strategy associated Details
R0295 DB00824 approved; experimental small molecule Enprofylline Indication associated Details
R0319 DB00875 approved; investigational; withdrawn small molecule Flupentixol Indication associated Details
R0757 DB05266 investigational small molecule Ibudilast Therapeutic strategy associated Details
R0932 DB06152 approved small molecule Nylidrin Indication associated Details
R1000 DB06397 investigational small molecule Nicaraven Indication associated Details
R1018 DB06448 approved; investigational small molecule Lonafarnib Therapeutic strategy associated Details
R1168 DB08842 approved; investigational small molecule Acetylcarnitine Therapeutic strategy associated Details
R1221 DB09092 approved; withdrawn small molecule Xanthinol Indication associated Details
R1235 DB09163 approved small molecule Technetium Tc-99m exametazime Indication associated Details
R1488 DB13191 nutraceutical small molecule Phosphocreatine Indication associated Details